本页面由Tiger Trade Technology Pte. Ltd.提供服务

Regulus Therapeutics Inc

8.16
0.0000
成交量:- -
成交额:7,591.12万
市值:5.65亿
市盈率:-11.28
高:8.16
开:8.16
低:8.16
收:8.16
52周最高:8.35
52周最低:0.8301
股本:6,923.41万
流通股本:5,293.84万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.7233
每股收益(LYR):-0.8227
净资产收益率:-53.82%
总资产收益率:-34.23%
市净率:8.18
市盈率(LYR):-9.92

数据加载中...

2022/08/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/11

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/07/15

重要事件披露

8-K - Current report
2022/06/27

重要事件披露

8-K - Current report
2022/06/13

重要事件披露

8-K - Current report
2022/05/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/12

重要事件披露

8-K - Current report
2022/03/11

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/10

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/02

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/12

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/01/05

重要事件披露

8-K - Current report
2022/01/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/09

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/12/08

SEC问询函

CORRESP [Cover] - Correspondence